To do this, we utilised the H1299-7 Beta-Arrestin 2 KO and MVP KO cell lines generated in this study, and a third human cell line, SKNBE-2, a neuroblastoma cell line with reduced SSTR2 expression and limited response to LuTate 19. The gene discussed is MVP; the disease is neuroblastoma.